Centers of Excellence

Heart & Vascular Center

Heart & Vascular Innovation and Discovery

Innovation leads to exceptional care. From developing the model for today’s defibrillators to our discovery that aspirin helps prevent heart attacks, our heart and vascular physician-researchers have continuously sought ways to improve patient care. Explore the sections below for an overview of some of the innovative heart and vascular techniques and technologies that have been developed at Brigham and Women’s Hospital, videos of innovative procedures, stories about patients who have benefitted from heart and vascular advances, and details about ongoing research.

Innovation leads to exceptional care. From developing the model for today’s defibrillators to our di

Innovation Timeline

For nearly a century of innovation, beginning with the world’s first successful heart valve surgery, BWH has been a leader in discovery and innovation leading to setting the standard of heart and vascular care.

This is a photo of the HeartMate 3 device for patients with end-stage heart failure.

HeartMate 3 Clinical Study

The surgically implanted HeartMate 3 is designed to act as a bridge to transplantation (short-term support) or as destination therapy (long-term support) for patients with end-stage heart failure.

This is a photo of the MitraClip, the transcatheter mitral valve repair therapy.

MitraClip Procedure

The MitraClip, the world’s first transcatheter mitral valve repair therapy, reduces regurgitation by tightening the mitral valve’s seal.

This is an image of DNA.

Innovation Videos

The BWH Heart & Vascular Center YouTube channel features videos from our heart and vascular physician researches on advances in cardiovascular diseases care and prevention.


Today there are more recipients waiting for organ transplants than there are organs available. And while the current opioid crisis has produced more available organs for transplantation, those with hepatitis C viral infection have previously been considered ineligible. With a new antiviral treatment regimen, could it be possible to transplant these organs, prevent the establishment of hepatitis C in the recipients, and produce an excellent outcome in patients? A team of infectious disease experts, transplant physicians and surgeons from the Brigham proved, with an effectiveness of 100 percent, that it is.


For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.

About BWH